Knockdown of USP18 Increases Alpha 2a Interferon Signaling and Induction of Interferon-Stimulating Genes but Does Not Increase Antiviral Activity in Huh7 Cells

Por Murray, E. J., Burden, Frances, Horscroft, Nigel, Smith-Burchnell, Caroline, Westby, Mike
Publicado em 2011

Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound Receptor for Entry

Por Westby, Mike, Smith-Burchnell, Caroline, Mori, Julie, Lewis, Marilyn, Mosley, Michael, Stockdale, Mark, Dorr, Patrick, Ciaramella, Giuseppe, Perros, Manos
Publicado em 2007

Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1

Por Corbau, Romuald, Mori, Julie, Phillips, Chris, Fishburn, Lesley, Martin, Alex, Mowbray, Charles, Panton, Wendy, Smith-Burchnell, Caroline, Thornberry, Adele, Ringrose, Heather, Knöchel, Thorsten, Irving, Steve, Westby, Mike, Wood, Anthony, Perros, Manos
Publicado em 2010

In Vitro Characterization of the Activity of PF-05095808, a Novel Biological Agent for Hepatitis C Virus Therapy

Por Lavender, Helen, Brady, Kevin, Burden, Frances, Delpuech-Adams, Oona, Denise, Hubert, Palmer, Amy, Perkins, Hannah, Savic, Boris, Scott, Sarah, Smith-Burchnell, Caroline, Troke, Phil, Wright, J. Fraser, Suhy, David, Corbau, Romu
Publicado em 2012

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type...

Por Dorr, Patrick, Westby, Mike, Dobbs, Susan, Griffin, Paul, Irvine, Becky, Macartney, Malcolm, Mori, Julie, Rickett, Graham, Smith-Burchnell, Caroline, Napier, Carolyn, Webster, Rob, Armour, Duncan, Price, David, Stammen, Blanda, Wood, Anthony, Perros, Manos
Publicado em 2005